Mifeprex Post-Marketing Restriction Compliance To Be Questioned By Rep. Souder
This article was originally published in The Pink Sheet Daily
Executive Summary
Danco Labs declined to testify at a hearing on deaths associated with the use of the abortifacient mifepristone.